We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. Adobe Inc. (NASDAQ:ADBE) is one of the stocks discussed by Jim Cramer Cramer frequently discusses productivity software firm Adobe Inc. (NASDAQ:ADBE) in his morning appear
We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. ServiceNow, Inc. (NYSE:NOW) is one of the stocks discussed by Jim Cramer Enterprise workflow management software provider ServiceNow, Inc. (NYSE:NOW)’s shares are down by
We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. Intuit Inc. (NASDAQ:INTU) is one of the stocks discussed by Jim Cramer Intuit Inc. (NASDAQ:INTU) is a productivity software provider. Its shares are down by 53% over the p
We recently published Jim Cramer Took A Side On Biggest AI Debate & Discussed These 13 Stocks. The Home Depot, Inc. (NYSE:HD) is one of the stocks discussed by Jim Cramer Home improvement retailer The Home Depot, Inc. (NYSE:HD)’s shares have struggled recently. They
Atlassian shares slide as a former engineer’s YouTube video reveals product details, raising concerns over competitive risks and AI disruption. Atlassian Corporation (NASDAQ:TEAM) faces scrutiny after a laid-off engineer posted a YouTube video detailing the company’s produ
Analysts project Nvidia’s dominance in AI chips will drive its valuation to $15 trillion within three years after surpassing $5 trillion in 2025. Nvidia (NASDAQ: NVDA) reached a $5 trillion market capitalization in October 2025, driven by surging demand for its AI chips. T
The hedge fund sold 330,983 shares of URGN in Q1, reducing its holding to 4.98% of reportable AUM. Superstring Capital Management reduced its position in UroGen Pharma Ltd. (NASDAQ:URGN) by 330,983 shares during the first quarter, resulting in an estimated $6.64 million sa
Fund acquires 730,548 shares in Vir Biotechnology Superstring Capital Management has established a new position in Vir Biotechnology, purchasing 730,548 shares in the first quarter. The estimated transaction value was $5.82 million based on quarterly average pricing. <
The firm disclosed an 815,333-share position in Astronics, valued at $59.07 million, amid strong stock performance. Pertento Partners disclosed a new $59.07 million stake in Astronics (NASDAQ:ATRO) during the first quarter, acquiring 815,333 shares. The position was valued
Pertento Partners reduced its Silicon Motion stake by 738,875 shares in Q1, trimming holdings despite strong stock performance. Pertento Partners sold 738,875 shares of Silicon Motion Technology (SIMO) in the first quarter, valued at $89.68 million based on average pricing
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.